+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Viral clearance Market By Method, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 288 Pages
  • July 2022
  • Region: Global
  • Allied Market Research
  • ID: 5671288
The global viral clearance market was valued at $425.93 million in 2021, and is projected to reach $977.84 million by 2031, registering a CAGR of 8.6% from 2022 to 2031.

Viral clearance is the removal of viral contamination using specialized membranes (mostly proteins) or chromatography. These protein solutions undergo viral clearance to inactivate or remove viral materials to ensure that therapeutic drugs derived from certain sources are fully rid of any viral contamination.

Viral clearance is a critical step in the manufacturing process that helps assure the safety of biologics such as biosimilars, antibodies, stem cell products, biopharmaceuticals, and others. Pharmaceutical and other product manufacturers need to be confirmed of its purification and manufacturing processes' capacity to inactivate or eliminate viruses or Transmissible spongiform encephalopathies(TSE) agents, as well as assure product safety.

The key factors that drive the growth of the market are rise in investments in the biotechnology and the pharmaceutical companies. There has been a rise in drug launches, increase in R&D investments, and rise in the possibility of cell culture contamination, recent advancements in nano-filtration technology, large economic burden and incidence of chronic diseases which is projected to provide huge opportunities for the growth of the viral clearance market. Along with this, rise in pharmaceutical outsourcing and increase in emerging markets are creating opportunities for the growth of the viral clearance market.

However, ever increasing cost and time-intensive drug development process are creating hurdles in the viral clearance market. In addition, increased degree of consolidation is also obstructing the growth of the market.

The viral clearance market is segmented on the basis of method, application, end user, and region. By method, it is categorized into viral removal, and viral inactivation. Viral removal is further divided into chromatography, nanofiltration, and precipitation. Viral inactivation is further categorized into low pH, solvent detergent method, heat pasteurization, and other viral inactivation methods. Depending on application, it is classified into recombinant proteins, blood and blood products, cellular and gene therapy products, vaccines, and other applications. By end user, it is categorized into pharmaceutical & biotechnology companies, contract research organizations, academic research institutes, and others.

Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).

North America accounted for the largest market share in the viral clearance market in 2021 and is expected to retain its dominance throughout the forecast period. This is primarily attributed to increase in demand for biopharmaceutical and upsurge in demand for advanced technologies in the purification of recombinant proteins produced by animal cell cultures to create high-value products of modern biotechnology.

The report provides a comprehensive analysis of the key players that operate in the global viral clearance market. The key companies profiled in the report include Allure Medical Group, Charles River Laboratories International, Inc., Clean Cells, Creative Biogene, Eurofins Scientific SE, Maravai Lifesciences Holding, Inc., Merck KGaA, Sartorius Stedium Biotech, Syngene International Limited, and Wuxi Biologics Inc.

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the viral clearance market analysis from 2021 to 2031 to identify the prevailing viral clearance market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the viral clearance market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global viral clearance market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Method

  • Viral Removal
  • Type
  • Chromatography
  • Nanofiltration
  • Precipitation
  • Viral Inactivation
  • Type
  • Low pH
  • Solvent Detergent Method
  • Heat Pasteurization
  • Other Viral Inactivation Methods

By Application

  • Recombinant Proteins
  • Blood and Blood Products
  • Cellular and Gene Therapy Products
  • Vaccine
  • Other Applications

By End User

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Academic Research Institutes
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Italy
  • Spain
  • Germany
  • France
  • UK
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players

  • ALLURE MEDICAL GROUP
  • Charles River Laboratories International, Inc.
  • CLEAN CELLS
  • CREATIVE BIOGENE
  • EUROFINS SCIENTIFIC SE
  • MARAVAI LIFESCIENCES HOLDINGS, INC.
  • MERCK KGAA
  • SARTORIUS STEDIM BIOTECH
  • SYNGENE INTERNATIONAL LIMITED
  • WUXI BIOLOGICS INC.
Frequently Asked Questions about the Global Viral Clearance Market

What is the estimated value of the Global Viral Clearance Market?

The Global Viral Clearance Market was estimated to be valued at $425.93 million in 2021.

What is the growth rate of the Global Viral Clearance Market?

The growth rate of the Global Viral Clearance Market is 8.7%, with an estimated value of $977.84 million by 2031.

What is the forecasted size of the Global Viral Clearance Market?

The Global Viral Clearance Market is estimated to be worth $977.84 million by 2031.

Who are the key companies in the Global Viral Clearance Market?

Key companies in the Global Viral Clearance Market include Allure Medical Group, Charles River Laboratories International, Inc., Clean Cells, Creative Biogene, Eurofins Scientific Se, Maravai Lifesciences Holdings, Inc., Merck Kgaa, Sartorius Stedim Biotech, Syngene International Limited and Wuxi Biologics Inc..

Table of Contents

CHAPTER 1: INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: VIRAL CLEARANCE MARKET, BY METHOD
4.1 Overview
4.1.1 Market size and forecast
4.2 Viral Removal
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.2.4 Viral Removal Viral clearance Market by Type
4.3 Viral Inactivation
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.3.4 Viral Inactivation Viral clearance Market by Type
CHAPTER 5: VIRAL CLEARANCE MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Recombinant Proteins
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Blood and Blood Products
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Cellular and Gene Therapy Products
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Vaccine
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
5.6 Other Applications
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market analysis by country
CHAPTER 6: VIRAL CLEARANCE MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Pharmaceutical and Biotechnology Companies
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Contract Research Organizations
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Academic Research Institutes
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Others
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
CHAPTER 7: VIRAL CLEARANCE MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Method
7.2.3 North America Market size and forecast, by Application
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Method
7.2.5.1.2 Market size and forecast, by Application
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Method
7.2.5.2.2 Market size and forecast, by Application
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Method
7.2.5.3.2 Market size and forecast, by Application
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Method
7.3.3 Europe Market size and forecast, by Application
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Method
7.3.5.1.2 Market size and forecast, by Application
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Method
7.3.5.2.2 Market size and forecast, by Application
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Method
7.3.5.3.2 Market size and forecast, by Application
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Method
7.3.5.4.2 Market size and forecast, by Application
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Method
7.3.5.5.2 Market size and forecast, by Application
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Method
7.3.5.6.2 Market size and forecast, by Application
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Method
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Method
7.4.5.1.2 Market size and forecast, by Application
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Method
7.4.5.2.2 Market size and forecast, by Application
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Method
7.4.5.3.2 Market size and forecast, by Application
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 Australia
7.4.5.4.1 Market size and forecast, by Method
7.4.5.4.2 Market size and forecast, by Application
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Method
7.4.5.5.2 Market size and forecast, by Application
7.4.5.5.3 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Method
7.4.5.6.2 Market size and forecast, by Application
7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Method
7.5.3 LAMEA Market size and forecast, by Application
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Method
7.5.5.1.2 Market size and forecast, by Application
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 South Africa
7.5.5.2.1 Market size and forecast, by Method
7.5.5.2.2 Market size and forecast, by Application
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 Saudi Arabia
7.5.5.3.1 Market size and forecast, by Method
7.5.5.3.2 Market size and forecast, by Application
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Method
7.5.5.4.2 Market size and forecast, by Application
7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 ALLURE MEDICAL GROUP
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Charles River Laboratories International, Inc.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 CLEAN CELLS
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 CREATIVE BIOGENE
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 EUROFINS SCIENTIFIC SE
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 MARAVAI LIFESCIENCES HOLDINGS, INC.
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 MERCK KGAA
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 SARTORIUS STEDIM BIOTECH
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 SYNGENE INTERNATIONAL LIMITED
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 WUXI BIOLOGICS INC.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
List of Tables
Table 1. Global Surgical Drill Market, by Product, 2021-2031 ($Million)
Table 2. Surgical Drill Market Size, for Instrument, by Region, 2021-2031 ($Million)
Table 3. Surgical Drill Market for Instrument, by Country, 2021-2031 ($Million)
Table 4. Global Instrument Surgical Drill Market, by Type, 2021-2031 ($Million)
Table 5. Surgical Drill Market Size, for Accessories, by Region, 2021-2031 ($Million)
Table 6. Surgical Drill Market for Accessories, by Country, 2021-2031 ($Million)
Table 7. Global Surgical Drill Market, by Application, 2021-2031 ($Million)
Table 8. Surgical Drill Market Size, for Orthopedic Surgery, by Region, 2021-2031 ($Million)
Table 9. Surgical Drill Market for Orthopedic Surgery, by Country, 2021-2031 ($Million)
Table 10. Surgical Drill Market Size, for Neurosurgery, by Region, 2021-2031 ($Million)
Table 11. Surgical Drill Market for Neurosurgery, by Country, 2021-2031 ($Million)
Table 12. Surgical Drill Market Size, for Ear Nose Throat, by Region, 2021-2031 ($Million)
Table 13. Surgical Drill Market for Ear Nose Throat, by Country, 2021-2031 ($Million)
Table 14. Surgical Drill Market Size, for Dental Surgery, by Region, 2021-2031 ($Million)
Table 15. Surgical Drill Market for Dental Surgery, by Country, 2021-2031 ($Million)
Table 16. Surgical Drill Market Size, for Others, by Region, 2021-2031 ($Million)
Table 17. Surgical Drill Market for Others, by Country, 2021-2031 ($Million)
Table 18. Global Surgical Drill Market, by End-user, 2021-2031 ($Million)
Table 19. Surgical Drill Market Size, for Hospitals, by Region, 2021-2031 ($Million)
Table 20. Surgical Drill Market for Hospitals, by Country, 2021-2031 ($Million)
Table 21. Surgical Drill Market Size, for Clinics, by Region, 2021-2031 ($Million)
Table 22. Surgical Drill Market for Clinics, by Country, 2021-2031 ($Million)
Table 23. Surgical Drill Market Size, for Ambulatory Surgical Centers, by Region, 2021-2031 ($Million)
Table 24. Surgical Drill Market for Ambulatory Surgical Centers, by Country, 2021-2031 ($Million)
Table 25. Surgical Drill Market Size, for Others, by Region, 2021-2031 ($Million)
Table 26. Surgical Drill Market for Others, by Country, 2021-2031 ($Million)
Table 27. Surgical Drill Market, by Region, 2021-2031 ($Million)
Table 28. North America Surgical Drill Market, by Product, 2021-2031 ($Million)
Table 29. North America Surgical Drill Market, by Application, 2021-2031 ($Million)
Table 30. North America Surgical Drill Market, by End-user, 2021-2031 ($Million)
Table 31. North America Surgical Drill Market, by Country, 2021-2031 ($Million)
Table 32. U.S. Surgical Drill Market, by Product, 2021-2031 ($Million)
Table 33. U.S. Surgical Drill Market, by Application, 2021-2031 ($Million)
Table 34. U.S. Surgical Drill Market, by End-user, 2021-2031 ($Million)
Table 35. Canada Surgical Drill Market, by Product, 2021-2031 ($Million)
Table 36. Canada Surgical Drill Market, by Application, 2021-2031 ($Million)
Table 37. Canada Surgical Drill Market, by End-user, 2021-2031 ($Million)
Table 38. Mexico Surgical Drill Market, by Product, 2021-2031 ($Million)
Table 39. Mexico Surgical Drill Market, by Application, 2021-2031 ($Million)
Table 40. Mexico Surgical Drill Market, by End-user, 2021-2031 ($Million)
Table 41. Europe Surgical Drill Market, by Product, 2021-2031 ($Million)
Table 42. Europe Surgical Drill Market, by Application, 2021-2031 ($Million)
Table 43. Europe Surgical Drill Market, by End-user, 2021-2031 ($Million)
Table 44. Europe Surgical Drill Market, by Country, 2021-2031 ($Million)
Table 45. Germany Surgical Drill Market, by Product, 2021-2031 ($Million)
Table 46. Germany Surgical Drill Market, by Application, 2021-2031 ($Million)
Table 47. Germany Surgical Drill Market, by End-user, 2021-2031 ($Million)
Table 48. France Surgical Drill Market, by Product, 2021-2031 ($Million)
Table 49. France Surgical Drill Market, by Application, 2021-2031 ($Million)
Table 50. France Surgical Drill Market, by End-user, 2021-2031 ($Million)
Table 51. UK Surgical Drill Market, by Product, 2021-2031 ($Million)
Table 52. UK Surgical Drill Market, by Application, 2021-2031 ($Million)
Table 53. UK Surgical Drill Market, by End-user, 2021-2031 ($Million)
Table 54. Italy Surgical Drill Market, by Product, 2021-2031 ($Million)
Table 55. Italy Surgical Drill Market, by Application, 2021-2031 ($Million)
Table 56. Italy Surgical Drill Market, by End-user, 2021-2031 ($Million)
Table 57. Spain Surgical Drill Market, by Product, 2021-2031 ($Million)
Table 58. Spain Surgical Drill Market, by Application, 2021-2031 ($Million)
Table 59. Spain Surgical Drill Market, by End-user, 2021-2031 ($Million)
Table 60. Rest of Europe Surgical Drill Market, by Product, 2021-2031 ($Million)
Table 61. Rest of Europe Surgical Drill Market, by Application, 2021-2031 ($Million)
Table 62. Rest of Europe Surgical Drill Market, by End-user, 2021-2031 ($Million)
Table 63. Asia-Pacific Surgical Drill Market, by Product, 2021-2031 ($Million)
Table 64. Asia-Pacific Surgical Drill Market, by Application, 2021-2031 ($Million)
Table 65. Asia-Pacific Surgical Drill Market, by End-user, 2021-2031 ($Million)
Table 66. Asia-Pacific Surgical Drill Market, by Country, 2021-2031 ($Million)
Table 67. China Surgical Drill Market, by Product, 2021-2031 ($Million)
Table 68. China Surgical Drill Market, by Application, 2021-2031 ($Million)
Table 69. China Surgical Drill Market, by End-user, 2021-2031 ($Million)
Table 70. Japan Surgical Drill Market, by Product, 2021-2031 ($Million)
Table 71. Japan Surgical Drill Market, by Application, 2021-2031 ($Million)
Table 72. Japan Surgical Drill Market, by End-user, 2021-2031 ($Million)
Table 73. India Surgical Drill Market, by Product, 2021-2031 ($Million)
Table 74. India Surgical Drill Market, by Application, 2021-2031 ($Million)
Table 75. India Surgical Drill Market, by End-user, 2021-2031 ($Million)
Table 76. Australia Surgical Drill Market, by Product, 2021-2031 ($Million)
Table 77. Australia Surgical Drill Market, by Application, 2021-2031 ($Million)
Table 78. Australia Surgical Drill Market, by End-user, 2021-2031 ($Million)
Table 79. South Korea Surgical Drill Market, by Product, 2021-2031 ($Million)
Table 80. South Korea Surgical Drill Market, by Application, 2021-2031 ($Million)
Table 81. South Korea Surgical Drill Market, by End-user, 2021-2031 ($Million)
Table 82. Rest of Asia-Pacific Surgical Drill Market, by Product, 2021-2031 ($Million)
Table 83. Rest of Asia-Pacific Surgical Drill Market, by Application, 2021-2031 ($Million)
Table 84. Rest of Asia-Pacific Surgical Drill Market, by End-user, 2021-2031 ($Million)
Table 85. LAMEA Surgical Drill Market, by Product, 2021-2031 ($Million)
Table 86. LAMEA Surgical Drill Market, by Application, 2021-2031 ($Million)
Table 87. LAMEA Surgical Drill Market, by End-user, 2021-2031 ($Million)
Table 88. LAMEA Surgical Drill Market, by Country, 2021-2031 ($Million)
Table 89. Brazil Surgical Drill Market, by Product, 2021-2031 ($Million)
Table 90. Brazil Surgical Drill Market, by Application, 2021-2031 ($Million)
Table 91. Brazil Surgical Drill Market, by End-user, 2021-2031 ($Million)
Table 92. Saudi Arabia Surgical Drill Market, by Product, 2021-2031 ($Million)
Table 93. Saudi Arabia Surgical Drill Market, by Application, 2021-2031 ($Million)
Table 94. Saudi Arabia Surgical Drill Market, by End-user, 2021-2031 ($Million)
Table 95. South Africa Surgical Drill Market, by Product, 2021-2031 ($Million)
Table 96. South Africa Surgical Drill Market, by Application, 2021-2031 ($Million)
Table 97. South Africa Surgical Drill Market, by End-user, 2021-2031 ($Million)
Table 98. Rest of LAMEA Surgical Drill Market, by Product, 2021-2031 ($Million)
Table 99. Rest of LAMEA Surgical Drill Market, by Application, 2021-2031 ($Million)
Table 100. Rest of LAMEA Surgical Drill Market, by End-user, 2021-2031 ($Million)
Table 101. Adeor Medical Ag: Company Snapshot
Table 102. Adeor Medical Ag: Operating Segments
Table 103. Adeor Medical Ag: Product Portfolio
Table 104. Adeor Medical Ag: Net Sales
Table 105. Adeor Medical Ag: Key Stratergies
Table 106. Allotech Co., Ltd: Company Snapshot
Table 107. Allotech Co., Ltd: Operating Segments
Table 108. Allotech Co., Ltd: Product Portfolio
Table 109. Allotech Co., Ltd: Net Sales
Table 110. Allotech Co., Ltd: Key Stratergies
Table 111. Arthrex Inc: Company Snapshot
Table 112. Arthrex Inc: Operating Segments
Table 113. Arthrex Inc: Product Portfolio
Table 114. Arthrex Inc: Net Sales
Table 115. Arthrex Inc: Key Stratergies
Table 116. B Braun Melsungen Ag: Company Snapshot
Table 117. B Braun Melsungen Ag: Operating Segments
Table 118. B Braun Melsungen Ag: Product Portfolio
Table 119. B Braun Melsungen Ag: Net Sales
Table 120. B Braun Melsungen Ag: Key Stratergies
Table 121. Brasseler Usa: Company Snapshot
Table 122. Brasseler Usa: Operating Segments
Table 123. Brasseler Usa: Product Portfolio
Table 124. Brasseler Usa: Net Sales
Table 125. Brasseler Usa: Key Stratergies
Table 126. Clearpoint Neuro, Inc.: Company Snapshot
Table 127. Clearpoint Neuro, Inc.: Operating Segments
Table 128. Clearpoint Neuro, Inc.: Product Portfolio
Table 129. Clearpoint Neuro, Inc.: Net Sales
Table 130. Clearpoint Neuro, Inc.: Key Stratergies
Table 131. Conmed Corporation: Company Snapshot
Table 132. Conmed Corporation: Operating Segments
Table 133. Conmed Corporation: Product Portfolio
Table 134. Conmed Corporation: Net Sales
Table 135. Conmed Corporation: Key Stratergies
Table 136. De Soutter Medical Ltd: Company Snapshot
Table 137. De Soutter Medical Ltd: Operating Segments
Table 138. De Soutter Medical Ltd: Product Portfolio
Table 139. De Soutter Medical Ltd: Net Sales
Table 140. De Soutter Medical Ltd: Key Stratergies
Table 141. Gpc Medical Ltd.: Company Snapshot
Table 142. Gpc Medical Ltd.: Operating Segments
Table 143. Gpc Medical Ltd.: Product Portfolio
Table 144. Gpc Medical Ltd.: Net Sales
Table 145. Gpc Medical Ltd.: Key Stratergies
Table 146. Johnson & Johnson: Company Snapshot
Table 147. Johnson & Johnson: Operating Segments
Table 148. Johnson & Johnson: Product Portfolio
Table 149. Johnson & Johnson: Net Sales
Table 150. Johnson & Johnson: Key Stratergies
Table 151. Joimax Inc.: Company Snapshot
Table 152. Joimax Inc.: Operating Segments
Table 153. Joimax Inc.: Product Portfolio
Table 154. Joimax Inc.: Net Sales
Table 155. Joimax Inc.: Key Stratergies
Table 156. Marver Med: Company Snapshot
Table 157. Marver Med: Operating Segments
Table 158. Marver Med: Product Portfolio
Table 159. Marver Med: Net Sales
Table 160. Marver Med: Key Stratergies
Table 161. Medtronic plc: Company Snapshot
Table 162. Medtronic plc: Operating Segments
Table 163. Medtronic plc: Product Portfolio
Table 164. Medtronic plc: Net Sales
Table 165. Medtronic plc: Key Stratergies
Table 166. Microaire Surgical Instruments, LLC.: Company Snapshot
Table 167. Microaire Surgical Instruments, LLC.: Operating Segments
Table 168. Microaire Surgical Instruments, LLC.: Product Portfolio
Table 169. Microaire Surgical Instruments, LLC.: Net Sales
Table 170. Microaire Surgical Instruments, LLC.: Key Stratergies
Table 171. Sofemed: Company Snapshot
Table 172. Sofemed: Operating Segments
Table 173. Sofemed: Product Portfolio
Table 174. Sofemed: Net Sales
Table 175. Sofemed: Key Stratergies
Table 176. Stryker Corporation: Company Snapshot
Table 177. Stryker Corporation: Operating Segments
Table 178. Stryker Corporation: Product Portfolio
Table 179. Stryker Corporation: Net Sales
Table 180. Stryker Corporation: Key Stratergies
Table 181. Zimmer Biomet Holdings, Inc.: Company Snapshot
Table 182. Zimmer Biomet Holdings, Inc.: Operating Segments
Table 183. Zimmer Biomet Holdings, Inc.: Product Portfolio
Table 184. Zimmer Biomet Holdings, Inc.: Net Sales
Table 185. Zimmer Biomet Holdings, Inc.: Key Stratergies
List of Figures
Figure 1. Viral Clearance Market Segmentation
Figure 2. Viral Clearance Market,2021-2031
Figure 3. Viral Clearance Market,2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Viral Clearance Market:Drivers, Restraints and Opportunities
Figure 12. Viral Clearance Market,By Method,2021(%)
Figure 13. Comparative Share Analysis of Viral Removal Viral Clearance Market,2021-2031(%)
Figure 14. Comparative Share Analysis of Viral Inactivation Viral Clearance Market,2021-2031(%)
Figure 15. Viral Clearance Market,By Application,2021(%)
Figure 16. Comparative Share Analysis of Recombinant Proteins Viral Clearance Market,2021-2031(%)
Figure 17. Comparative Share Analysis of Blood and Blood Products Viral Clearance Market,2021-2031(%)
Figure 18. Comparative Share Analysis of Cellular and Gene Therapy Products Viral Clearance Market,2021-2031(%)
Figure 19. Comparative Share Analysis of Vaccine Viral Clearance Market,2021-2031(%)
Figure 20. Comparative Share Analysis of Other Applications Viral Clearance Market,2021-2031(%)
Figure 21. Viral Clearance Market,By End-user,2021(%)
Figure 22. Comparative Share Analysis of Pharmaceutical and Biotechnology Companies Viral Clearance Market,2021-2031(%)
Figure 23. Comparative Share Analysis of Contract Research Organizations Viral Clearance Market,2021-2031(%)
Figure 24. Comparative Share Analysis of Academic Research Institutes Viral Clearance Market,2021-2031(%)
Figure 25. Comparative Share Analysis of Others Viral Clearance Market,2021-2031(%)
Figure 26. Viral Clearance Market by Region,2021
Figure 27. U.S. Viral Clearance Market,2021-2031($Million)
Figure 28. Canada Viral Clearance Market,2021-2031($Million)
Figure 29. Mexico Viral Clearance Market,2021-2031($Million)
Figure 30. Germany Viral Clearance Market,2021-2031($Million)
Figure 31. France Viral Clearance Market,2021-2031($Million)
Figure 32. Uk Viral Clearance Market,2021-2031($Million)
Figure 33. Italy Viral Clearance Market,2021-2031($Million)
Figure 34. Spain Viral Clearance Market,2021-2031($Million)
Figure 35. Rest of Europe Viral Clearance Market,2021-2031($Million)
Figure 36. China Viral Clearance Market,2021-2031($Million)
Figure 37. Japan Viral Clearance Market,2021-2031($Million)
Figure 38. India Viral Clearance Market,2021-2031($Million)
Figure 39. Australia Viral Clearance Market,2021-2031($Million)
Figure 40. South Korea Viral Clearance Market,2021-2031($Million)
Figure 41. Rest of Asia-Pacific Viral Clearance Market,2021-2031($Million)
Figure 42. Brazil Viral Clearance Market,2021-2031($Million)
Figure 43. South Africa Viral Clearance Market,2021-2031($Million)
Figure 44. Saudi Arabia Viral Clearance Market,2021-2031($Million)
Figure 45. Rest of LAMEA Viral Clearance Market,2021-2031($Million)
Figure 46. Top Winning Strategies, by Year
Figure 47. Top Winning Strategies, by Development
Figure 48. Top Winning Strategies, by Company
Figure 49. Product Mapping of Top 10 Players
Figure 50. Competitive Dashboard
Figure 51. Competitive Heatmap of Top 10 Key Players
Figure 52. Allure Medical Group.: Net Sales ,($Million)
Figure 53. Charles River Laboratories International, Inc..: Net Sales ,($Million)
Figure 54. Clean Cells.: Net Sales ,($Million)
Figure 55. Creative Biogene.: Net Sales ,($Million)
Figure 56. Eurofins Scientific SE.: Net Sales ,($Million)
Figure 57. Maravai Lifesciences Holdings, Inc..: Net Sales ,($Million)
Figure 58. Merck KGaA.: Net Sales ,($Million)
Figure 59. Sartorius Stedim Biotech.: Net Sales ,($Million)
Figure 60. Syngene International Limited.: Net Sales ,($Million)
Figure 61. Wuxi Biologics Inc..: Net Sales ,($Million)

Executive Summary

According to the report, titled, “Viral clearance Market," the viral clearance market size was $425.93 million in 2021, and is estimated to reach $977.8 million by 2031, growing at a CAGR of 8.6% from 2022 to 2031.

Viral detection and clearance is performed to demonstrate clearance of viruses known to be related to a process. Viral clearance services industry are useful before launching a biologic to the market.

There is no such test present to detect all viruses at once, which lead to a minimum level of viruses test for detection. Some methods measure markers of infection, providing results long after infection occurs. Hence, ensuring that a product is free from viral contamination depends on ensuring that a process can inactivate or remove viruses as well as testing for their presence. Such an approach is the only way to ensure that biopharmaceuticals will be free from viral contamination and safe for human use. It is also important to recognize which viruses can possibly contaminate a product and enter its manufacturing process.

The viral clearance market is segmented on the basis of method, application, end user, and region. By method, it is categorized into viral removal, and viral inactivation. Viral removal is further divided into chromatography, nanofiltration, and precipitation. Viral inactivation is further categorized into low pH, solvent detergent method, heat pasteurization, and other viral inactivation methods. Depending on application, it is classified into recombinant proteins, blood and blood products, cellular and gene therapy products, vaccines, and other applications. By end user, it is categorized into pharmaceutical & biotechnology companies, contract research organizations, academic research institutes, and others.

Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).

By method, the viral removal segment currently dominates the global viral clearance market share and is expected to remain dominant during the forecast period, owing to increase in awareness about the benefits of using viral removals among healthcare professionals and consumers fueling the demand for the viral removals. By application, the recombinant proteins segment dominated the market in 2021, and this trend is expected to continue during the forecast period owing to continuous rise of chronic illnesses across the globe. Apart from the surge in chronic diseases, the rise in funding of the worldwide government on R&D activities are also fuelling the viral clearance market growth efficiently. By end user, the pharmaceutical and biotechnology companies segment dominated the market in 2021, and this trend is expected to continue during the forecast period owing to increase in utilization of viral clearance processing during production of biopharmaceuticals, and key players operating in the market are adopting various key strategies to expand their business and rising investment on R&D segment, these also form key viral clearance market trends.

By region, North America accounted for the largest market share in the viral clearance testing industry in 2021 and is expected to retain its dominance throughout the forecast period. This is primarily attributed to increase in demand for biopharmaceutical and upsurge in demand for advanced technologies in the purification of recombinant proteins produced by animal cell cultures to create high-value products of modern biotechnology.

Asia-Pacific witnessed the highest growth rate for the viral clearance market and is expected to continue this trend throughout the forecast period, which is attributed to its R&D activities for biopharmaceuticals, rise in investments made by the market players and increase in government support.

The report provides a comprehensive analysis of the key players that operate in the global viral clearance market. The key companies profiled in the report include Allure Medical Group, Charles River Laboratories International, Inc., Clean Cells, Creative Biogene, Eurofins Scientific SE, Maravai Lifesciences Holding, Inc., Merck KGaA, Sartorius Stedium Biotech, Syngene International Limited, and Wuxi Biologics Inc.

Key Findings of the Study

  • On the basis of method, the viral removal segment held 59.39% share in the global market in 2021.
  • On the basis of application, the recombinant proteins segment held the largest market share in 2021, and is expected to remain dominant throughout the forecast period.
  • On the basis of end user, the pharmaceutical and biotechnology companies segment held the largest market share in 2021, and is expected to remain dominant throughout the forecast period.
  • Region wise, North America is expected to experience the highest market share during the forecast period. This was attributed to biopharmaceutical and upsurge in demand for advanced technologies in the purification of recombinant proteins produced by animal cell cultures to create high-value products of modern biotechnology.

Companies Mentioned

  • Allure Medical Group
  • Charles River Laboratories International, Inc.
  • Clean Cells
  • Creative Biogene
  • Eurofins Scientific Se
  • Maravai Lifesciences Holdings, Inc.
  • Merck Kgaa
  • Sartorius Stedim Biotech
  • Syngene International Limited
  • Wuxi Biologics Inc.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...